SARS-CoV-2 Nucleoprotein CTD Domain | abx163975
- Usually shipped in 5 working days
SARS-CoV-2 Nucleoprotein CTD Domain. Cat# abx163975. Supplier: abbexa.
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Nucleoprotein CTD Domain is a recombinant protein expressed in E. coli.
The SARS-CoV-2 Nucleoprotein (also known as Nucleocapsid Protein or N Protein) is a protein that binds to the RNA in the viral particle. Changes to two amino acids in the nucleoprotein are thought to contribute to the virus’ ability to infect humans; this mutation allows the virus to reduce the binding capability of an HLA-C allele found in many Europeans. The nucleoprotein is the second most-common protein in SARS-CoV-2 targeted by the immune system, after the spike protein.
|Target||Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Nucleoprotein CTD Domain|
|Tested Applications||ELISA, WB, SDS-PAGE|
|Recommended dilutions||Optimal dilutions/concentrations should be determined by the end user.|
|Purity||> 95% (SDS-PAGE)|
|Purification||0.2 µm filtered.|
|Storage||Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.|
|Tag||N-terminal 6x His-tag.|
|Buffer||PBS, 2 M Urea, pH 7.4.|
|Endotoxin Level||< 0.1 ng/µg (1 IEU/µg) as determined by LAL test.|
|Availability||Shipped within 5-10 working days.|
|Note||This product is for research use only.|